Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Worswick who wrote (1081)	2/20/1998 5:21:00 PM
From: Premier	Read Replies (1) \| Respond to of 2068

Edmund Kroll of Furman Selz recommended the stock on 05/9/97 with price target of 80. Zacks opinion on his opinion was " not made enough forecasts to be meaningfully ranked relative to other analysts following Oxford." Furman Selz has issued another report on 1/28/98 perhaps by Hoehn. I do not have access to this report. Hoehn does not appear to be optimistic about success of Oxford even after KKR/Payson installation. I think Hoehn believes Oxford is buying $600MM+ of band-aid for its terminal illness. IMHO, time will prove Hoehn wrong. Premier